Automated technologies and novel techniques to accelerate protein crystallography for structural genomics

Proteomics
Babu A ManjasettyMark R Chance

Abstract

The sequence infrastructure that has arisen through large-scale genomic projects dedicated to protein analysis, has provided a wealth of information and brought together scientists and institutions from all over the world. As a consequence, the development of novel technologies and methodologies in proteomics research is helping to unravel the biochemical and physiological mechanisms of complex multivariate diseases at both a functional and molecular level. In the late sixties, when X-ray crystallography had just been established, the idea of determining protein structure on an almost universal basis was akin to an impossible dream or a miracle. Yet only forty years after, automated protein structure determination platforms have been established. The widespread use of robotics in protein crystallography has had a huge impact at every stage of the pipeline from protein cloning, over-expression, purification, crystallization, data collection, structure solution, refinement, validation and data management- all of which have become more or less automated with minimal human intervention necessary. Here, recent advances in protein crystal structure analysis in the context of structural genomics will be discussed. In addition, this re...Continue Reading

References

Feb 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·A T Hagler, B Honig
Jan 1, 1990·Annual Review of Biophysics and Biophysical Chemistry·H Hope
Feb 1, 1988·Acta Crystallographica. Section B, Structural Science·H Hope
Sep 5, 1993·Journal of Molecular Biology·L Holm, C Sander
Jun 1, 1996·Current Opinion in Structural Biology·J F GibratS H Bryant
Nov 14, 1997·Structure·N E Chayen
Oct 8, 1998·Acta Crystallographica. Section D, Biological Crystallography·J M HarpG J Bunick
Oct 8, 1998·Acta Crystallographica. Section D, Biological Crystallography·J I Yeh, W G Hol
Oct 31, 1998·Protein Engineering·I N Shindyalov, P E Bourne
Dec 10, 1998·Nucleic Acids Research·L Holm, C Sander
Mar 25, 1999·Acta Crystallographica. Section D, Biological Crystallography·T C Terwilliger, J Berendzen
Mar 25, 1999·Acta Crystallographica. Section D, Biological Crystallography·C M Weeks, R Miller
May 18, 1999·Acta Crystallographica. Section D, Biological Crystallography·M A WalshA Joachimiak
Jul 7, 1999·Acta Crystallographica. Section D, Biological Crystallography·J M HarpG J Bunick
Oct 3, 1999·Nature Genetics·S K BurleyS Swaminathan
Oct 26, 1999·Acta Crystallographica. Section D, Biological Crystallography·M G Rossmann, C G van Beek
Oct 26, 1999·Acta Crystallographica. Section D, Biological Crystallography·J W Pflugrath
Oct 26, 1999·Acta Crystallographica. Section D, Biological Crystallography·D Bourgeois
Apr 20, 2000·Acta Crystallographica. Section D, Biological Crystallography·V R SamyginaA N Popov
Aug 16, 2000·Acta Crystallographica. Section D, Biological Crystallography·T C Terwilliger
Nov 28, 2000·Acta Crystallographica. Section D, Biological Crystallography·A Vagin, A Teplyakov
Apr 26, 2001·Acta Crystallographica. Section D, Biological Crystallography·K L LongeneckerZ S Derewenda
Sep 22, 2001·Acta Crystallographica. Section D, Biological Crystallography·J Navaza
Nov 22, 2001·Acta Crystallographica. Section D, Biological Crystallography·R A de GraaffJ P Abrahams
Sep 28, 2002·Acta Crystallographica. Section D, Biological Crystallography·Thomas R Schneider, George M Sheldrick
Sep 28, 2002·Acta Crystallographica. Section D, Biological Crystallography·W I KarainH D Bartunik
Oct 24, 2002·Acta Crystallographica. Section D, Biological Crystallography·A G W LeslieC Nave
Nov 28, 2002·Acta Crystallographica. Section D, Biological Crystallography·Agnieszka MatejaZygmunt S Derewenda
Feb 11, 2003·Structure·Begoña HerasJennifer L Martin
Mar 19, 2003·Accounts of Chemical Research·Udo HeinemannPatrick Umbach
Jun 24, 2003·Nature Structural Biology·Raymond C TrievelJames H Hurley
Jul 2, 2003·Acta Crystallographica. Section D, Biological Crystallography·Elizabeth PottertonEleanor Dodson
Dec 1, 1961·Scientific American·J C KENDREW
Oct 22, 2003·Current Opinion in Structural Biology·Carl Hansen, Stephen R Quake
Oct 28, 2003·Proteins·Eugene Melamud, John Moult
Oct 28, 2003·Proteins·Ranjit Prasad BahadurJoël Janin
Nov 8, 2003·Structure·Rune LindingRobert B Russell
Dec 4, 2003·Journal of Synchrotron Radiation·Yurii GaponovSoichi Wakatsuki

❮ Previous
Next ❯

Citations

Jun 8, 2010·Journal of Structural and Functional Genomics·M CymborowskiW Minor
Jul 1, 2009·Nature Methods·Audur MagnusdottirHelena Berglund
Oct 22, 2008·Nucleic Acids Research·Florian KieferTorsten Schwede
Mar 23, 2013·Acta Crystallographica. Section D, Biological Crystallography·Mohammad Yaser Heidari KhajepourJean-Luc Ferrer
Dec 24, 2009·Journal of Synchrotron Radiation·Gerd WellenreutherWolfram Meyer-Klaucke
Aug 18, 2010·BMC Research Notes·Bhusan K KuntalPallu Reddanna
Jan 1, 2010·Biotechnology & Genetic Engineering Reviews·Babu ManjasettySantosh Panjikar
Mar 19, 2014·Acta Crystallographica. Section F, Structural Biology Communications·Marc C Deller, Bernhard Rupp
Feb 10, 2012·Current Pharmaceutical Design·Lu ChenShuxing Zhang
May 10, 2013·Expert Opinion on Drug Discovery·Jean-Luc FerrerDidier Nurizzo
Oct 4, 2015·Methods : a Companion to Methods in Enzymology·Sarah J RoutledgeRoslyn M Bill
May 29, 2012·Journal of Pharmaceutical and Biomedical Analysis·Zsuzsanna Kálmán-SzekeresKatalin Ganzler
Jun 2, 2009·Current Opinion in Microbiology·Thomas R Ioerger, James C Sacchettini
May 9, 2009·Drug Discovery Today·Claudio N Cavasotto, Sharangdhar S Phatak
Mar 17, 2009·Toxicon : Official Journal of the International Society on Toxinology·Raymond S Norton
Dec 19, 2014·Interdisciplinary Sciences, Computational Life Sciences·Periyasamy VijayalakshmiManikkam Rajalakshmi
Nov 7, 2014·Interdisciplinary Sciences, Computational Life Sciences·Periyasamy VijayalakshmiManikkam Rajalakshmi
Mar 8, 2016·Expert Opinion on Drug Discovery·Alain Chavanieu, Martine Pugnière
Sep 13, 2011·Methods : a Companion to Methods in Enzymology·Ian M Overton, Geoffrey J Barton
Aug 5, 2008·Current Opinion in Structural Biology·Elisabeth P CarpenterSo Iwata
Apr 27, 2016·Journal of Theoretical Biology·Mozafar MohammadiNeda Zarei
Jun 2, 2016·DNA Repair·Norie SugitaniWalter J Chazin
Sep 26, 2012·Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics·Yan FengBin Liu
Aug 24, 2017·International Journal of Biological Macromolecules·Jashandeep KaurJagdeep Kaur

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.